- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT03908034
Consumer Motivation for Disease Prevention
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
People sometimes have to deliberate on whether or not to remove a risk factor that may potentially cause a disease in the future. When a controllable risk factor (say, X) is the only factor that causes a disease, the decision to remove it may simply depend on the probabilistic relationship between X and an outcome, as well as the cost of removing X. However, little is known when other factors that are out of the decision-maker's control are also present. The main question being asked here is how does the presence of such uncontrollable factors change people's decision to remove X.
Specifically, the investigators consider two cases: a disease caused by a single controllable risk factor (say X) and a disease caused by two risk factors -- a controllable factor (X) and an uncontrollable factor (Y). In both cases, the removal of X can result in a meaningful reduction in overall disease risk. It is hypothesized that even when the magnitude of overall risk reduction brought by the removal of X is the same in the two cases, people would have a lower motivation to remove X in the latter case.
The investigators also examine how the presence of an uncontrollable risk factor interacts with the respondents' regret anticipation to influence their decision to remove X. In the context of the current research, regret anticipation could take one of the following forms: (a) feel regretful if one decides not to remove X and later develops the disease (b) feel regretful if one decides to remove X but still develops the disease. The investigators expect (a) to moderate the effect of uncontrollable risk factor on motivation to remove X.
Tipo de estudo
Inscrição (Antecipado)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
-
Hong Kong, Hong Kong
- Recrutamento
- Chinese University of Hong Kong
-
Contato:
- Wing Man Yeung, PhD
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- students enrolled in marketing courses at the Chinese University of Hong Kong
Exclusion Criteria:
- None
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Outro
- Alocação: Randomizado
- Modelo Intervencional: Atribuição fatorial
- Mascaramento: Dobro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Sem intervenção: Uncontrollable factor ABSENT; NO anticipated regret induced
The experiment comprises 10 rounds of decision tasks. For each round, the participant begins with having 130 points, each worth $0.5 (Hong Kong dollars). Different numbers of points are deducted depending on the outcome in each round. After the 10 rounds, the computer randomly selects 1 of the rounds and the points from this round is paid in cash. There is a chance for the participant to develop a disease. Without prevention, the chance of getting the disease is 60%. A cause, X, is identified for the disease. The participant has to decide whether or not to remove X. Removal of X reduces disease chance; the reduced chance varies between 10% and 50% across the 10 rounds and the exact level is communicated at the beginning of each round. The removal of X costs 30 points. Whether s/he ends up developing the disease or not is determined by a computerized lottery based on these chances. If s/he develops the disease, s/he will lose 100 points. |
|
|
Experimental: Uncontrollable factor ABSENT; anticipated regret induced
Same description as in the "uncontrollable factor absent, no anticipated regret induced" arm, except that the participants are induced to think to what extent they will feel regretful: a) if s/he decides not to remove X but ends up developing the disease and b) if s/he decides to remove X but still gets the disease.
|
nível mais alto de elaboração sobre arrependimento potencial
|
|
Experimental: Uncontrollable factor PRESENT; NO anticipated regret induced
The experiment comprises 10 rounds of decision tasks. For each round, the participant begins with having 130 points, each worth $0.5. Different numbers of points are deducted depending on the outcome in each round. After the 10 rounds, the computer randomly selects 1 of the rounds and the points from this round is paid in cash. There is a chance for the participant to develop a disease. Without prevention, the chance of getting the disease is 60%. Two causes, X and Y, are identified for the disease. The participant has to decide whether or not to remove X. Removal of X reduces disease chance; the reduced chance varies between 10% and 50% across the 10 rounds and the exact level is communicated at the beginning of each round. The removal of X costs 30 points. Whether s/he ends up developing the disease or not is determined by a computerized lottery based on these chances. If s/he develops the disease, s/he will lose 100 points. |
the presence of an uncontrollable / unremovable risk factor for a disease
|
|
Experimental: Uncontrollable factor PRESENT; anticipated regret induced
Same as the "uncontrollable factor present, no anticipated regret induced" arm, except that the participants are induced to think to what extent they will feel regretful: a) if s/he decides not to remove X but ends up developing the disease and b) if s/he decides to remove X but still gets the disease.
|
nível mais alto de elaboração sobre arrependimento potencial
the presence of an uncontrollable / unremovable risk factor for a disease
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Decisão de remover X
Prazo: Dia 1: Ao responder ao questionário
|
A decisão de remover X (sim vs. não)
|
Dia 1: Ao responder ao questionário
|
Outras medidas de resultado
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Anticipated regret
Prazo: Day 1: When responding to the questionnaire.
|
The exact question is: Some people may engage in the following thoughts when they make their decisions: "I may regret if I do not remove X and end up getting the disease" OR "I may regret if I remove X but still get the disease."
To what extent have you engaged in any of these thoughts?
(Measurement scale: 1 = not at all; 7 = a lot)
|
Day 1: When responding to the questionnaire.
|
|
Judgment of whether the removal of X is an opportunity to improve earnings
Prazo: Day 1: When responding to the questionnaire.
|
The exact question is: Do you think the decision to remove X is an opportunity for you to improve your final earnings?
(Measurement scale: 1 = not a good opportunity at all; 7 = a very good opportunity")
|
Day 1: When responding to the questionnaire.
|
|
Sense of control over the final outcome
Prazo: Day 1: When responding to the questionnaire.
|
The exact question is: Do you think you have control over the outcome through your decision of whether or not to remove X? (Measurement scale: 1 = I have very little control… 7 = I have a lot of control)
|
Day 1: When responding to the questionnaire.
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Wing Man Yeung, PhD, Chinese University of Hong Kong
Publicações e links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Antecipado)
Conclusão do estudo (Antecipado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Outros números de identificação do estudo
- 14507018
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Prazo de Compartilhamento de IPD
Critérios de acesso de compartilhamento IPD
Tipo de informação de suporte de compartilhamento de IPD
- PROTOCOLO DE ESTUDO
- SEIVA
- ANALYTIC_CODE
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .